Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Nano Lett. 2022 May 11;22(9):3761-3769. doi: 10.1021/acs.nanolett.2c00724. Epub 2022 May 2.
Cancer-derived small extracellular vesicles (sEVs) are potential circulating biomarkers in liquid biopsies. However, their small sizes, low abundance, and heterogeneity in molecular makeups pose major technical challenges for detecting and characterizing them quantitatively. Here, we demonstrate a single-sEV enumeration platform using lanthanide-doped upconversion nanoparticles (UCNPs). Taking advantage of the unique optical properties of UCNPs and the background-eliminating property of total internal reflection fluorescence (TIRF) imaging technique, a single-sEV assay recorded a limit of detection 1.8 × 10 EVs/mL, which was nearly 3 orders of magnitude lower than the standard enzyme-linked immunosorbent assay (ELISA). Its specificity was validated by the difference between EpCAM-positive and EpCAM-negative sEVs. The accuracy of the UCNP-based single-sEV assay was benchmarked with immunomagnetic-beads flow cytometry, showing a high correlation (> 0.99). The platform is suitable for evaluating the heterogeneous antigen expression of sEV and can be easily adapted for biomarker discoveries and disease diagnosis.
癌症来源的小细胞外囊泡 (sEVs) 是液体活检中潜在的循环生物标志物。然而,它们的体积小、丰度低以及分子组成的异质性给定量检测和表征带来了重大技术挑战。在这里,我们展示了一种使用镧系掺杂上转换纳米粒子 (UCNPs) 的单个 sEV 计数平台。利用 UCNPs 的独特光学性质和全内反射荧光 (TIRF) 成像技术的背景消除特性,单个 sEV 分析记录的检测限为 1.8×10 EVs/mL,比标准酶联免疫吸附测定 (ELISA) 低近 3 个数量级。其特异性通过 EpCAM 阳性和 EpCAM 阴性 sEVs 的差异得到验证。基于 UCNP 的单个 sEV 分析的准确性与免疫磁珠流式细胞术进行了基准测试,相关性很高 (>0.99)。该平台适用于评估 sEV 的异质抗原表达,并且易于适应生物标志物发现和疾病诊断。